title: Anti-IL-6 antibody treatment but not IL-6 knockout improves intestinal barrier function and reduces inflammation after binge ethanol exposure and burn injury.
abstract: Interleukin 6 (IL-6) is an inflammatory cytokine known to be elevated in chronic diseases and after insults such as trauma and infection. Although necessary for the development of B cells and Th17 cells, IL-6, at elevated levels, can also cause tissue damage and lead to a rise in inflammation. Previous work in our laboratory has shown that IL-6 is increased both systemically and in multiple organ systems including the ileum after ethanol exposure and burn injury. As this combined insult causes elevated intestinal morphological damage, tight junction protein localization alterations, and phosphorylated myosin light chain levels, we sought to determine the role of IL-6 in these intestinal responses using a model of binge ethanol exposure and burn injury. Interleukin 6 antibody treatment after the combined insult reduced morphological changes in the ileum, bacterial translocation, and phosphorylated myosin light chain levels relative to either injury alone. Zonula occludens protein 1 and occludin localization was also reestablished in wild-type mice given IL-6 antibody after ethanol and burn. Interleukin 6-knockout mice given ethanol and burn injury also had reduced intestinal damage; however, no changes in bacterial translocation or tight junction protein localization were observed as compared with similarly treated wild-type mice. These data suggest that IL-6 may have a role in intestinal tissue damage observed after the combined insult of binge ethanol exposure and burn injury, although complete loss of IL-6 does not seem to be beneficial in this model. Modulation of IL-6 may present a new option for preventing intestinal damage and associated inflammation after a combined insult of ethanol exposure and burn injury.
authors: Molecular and Cellular Biochemistry Program, Department of Surgery, Loyola University, Medical Center, Maywood, Illinois 60153, USA.
authors: Anita
authors: A
authors: Zahs
authors: Melanie D
authors: MD
authors: Bird
authors: Luis
authors: L
authors: Ramirez
authors: Mashkoor A
authors: MA
authors: Choudhry
authors: Elizabeth J
authors: EJ
authors: Kovacs
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D018988:Bacterial Translocation / Q000187:drug effects / Q000276:immunology; D063425:Binge Drinking / Q000276:immunology; D002056:Burns / Q000503:physiopathology*; D016207:Cytokines / Q000378:metabolism; D000431:Ethanol / Q000633:toxicity*; D007079:Ileitis / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*; D015850:Interleukin-6 / Q000172:deficiency / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018994:Myosin Light Chains / Q000378:metabolism; D062793:Occludin / Q000378:metabolism; D012997:Solvents / Q000633:toxicity*; D062826:Zonula Occludens-1 Protein / Q000378:metabolism; D000093242:Interleukin-6 Inhibitors
chemical_list: D000906:Antibodies; D016207:Cytokines; D000431:Ethanol; D015850:Interleukin-6; D018994:Myosin Light Chains; D062793:Occludin; D012997:Solvents; D062826:Zonula Occludens-1 Protein; D000093242:Interleukin-6 Inhibitors
references: Burns. 2005 May;31(3):290-6
references: 15774282
references: J Leukoc Biol. 2006 Aug;80(2):227-36
references: 16707558
references: J Surg Res. 1998 Sep;79(1):39-46
references: 9735238
references: Am J Physiol Regul Integr Comp Physiol. 2001 Sep;281(3):R1013-23
references: 11507020
references: Alcohol Clin Exp Res. 2000 Sep;24(9):1392-9
references: 11003205
references: Pathophysiology. 2006 Feb 21;13(1):39-49
references: 16099144
references: Trends Mol Med. 2008 Mar;14(3):109-19
references: 18261959
references: Cancer Cell. 2009 Feb 3;15(2):103-13
references: 19185845
references: J Am Coll Surg. 1994 Apr;178(4):357-62
references: 8149035
references: Gut. 2003 Jan;52(1):65-70
references: 12477762
references: Shock. 2008 Mar;29(3):377-83
references: 18000475
references: J Burn Care Res. 2008 Mar-Apr;29(2):323-30
references: 18354289
references: Biochem J. 2003 Aug 15;374(Pt 1):1-20
references: 12773095
references: J Surg Res. 2009 Dec;157(2):187-92
references: 19482301
references: J Leukoc Biol. 1998 Dec;64(6):724-32
references: 9850153
references: Alcohol Clin Exp Res. 2010 Oct;34(10):1733-41
references: 20608903
references: Cell Mol Immunol. 2004 Jun;1(3):205-11
references: 16219169
references: Hepatology. 2004 Oct;40(4):933-41
references: 15382116
references: J Biol Chem. 2011 Sep 9;286(36):31263-71
references: 21771795
references: J Leukoc Biol. 1997 Dec;62(6):733-40
references: 9400814
references: J Leukoc Biol. 1999 Sep;66(3):471-80
references: 10496318
references: Crit Care Med. 2004 Nov;32(11):2267-73
references: 15640640
references: Am J Physiol Gastrointest Liver Physiol. 2003 Sep;285(3):G621-9
references: 12773301
references: J Trauma. 2009 Dec;67(6):1162-8
references: 20009662
references: Gastroenterology. 2007 Jun;132(7):2383-94
references: 17570213
references: Shock. 2002 Jun;17(6):463-7
references: 12069181
references: J Biol Chem. 2007 Mar 16;282(11):8219-27
references: 17213200
references: Burns. 1999 Aug;25(5):403-10
references: 10439148
references: World J Gastroenterol. 2009 Aug 7;15(29):3621-30
references: 19653339
references: Crit Care. 2008;12(3):R81
references: 18564432
references: J Clin Invest. 2005 Oct;115(10):2702-15
references: 16184195
references: Am J Physiol Gastrointest Liver Physiol. 2012 Sep 15;303(6):G705-12
references: 22790598
references: Gastroenterology. 1993 May;104(5):1285-92
references: 7683293
references: J Surg Res. 2002 May 15;104(2):118-23
references: 12020130